Author

Alba Hermoso-López

Universidad Complutense de Madrid

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Manuel GuzmániD· 2 shared Abigail K. D. PorteriD· 1 shared Alicia Álvaro-BlázqueziD· 1 shared Andrea Sánchez-RuiziD· 1 shared Carlos Costas‐InsuaiD· 1 shared Carlos Montero-FernándeziD· 1 shared Christina M. WooiD· 1 shared Cristina BlázqueziD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

Manuel GuzmánORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistryNature Chemical BiologyPeer-reviewedDec 29, 2025

PCMT1 generates the C-terminal cyclic imide degron on CRBN substrates

Zhenguang Zhao, Wenqing Xu, Ethan Yang Feng…·Christina M. Woo

The paper identifies PCMT1 as an enzyme that forms C-terminal cyclic imides on CRBN substrates, linking it to metabolic enzyme regulation and epileptic phenotypes.

13 citationstop 5%

mouseexperimental assay

𝕏 PostBluesky

NeuroscienceEMBO Molecular MedicinePeer-reviewedMar 21, 2024

The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls

Carlos Costas‐Insua, Alba Hermoso-López, Estefanía Moreno…·Manuel Guzmán

This study identifies CB1R overactivation as a driver of CRBN deficiency-linked ARNSID and suggests CB1R blockade as a potential therapy.

3 citations

mouseexperimental assay

𝕏 PostBluesky